Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of KIR3DL2 Receptor and IPH4102 in Blood Samples From Axial Spondyloarthritis Patients
NCT03322618Completed
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Dec 2017
- Primary completion
- Sep 2019
- Countries
- 1
01
Overview
Trial (3 arms), sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoint: Characterization of immune cell populations at 12 months. Started Dec 2017; status: completed.
Beyond the preview
Go deeper on NCT03322618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03322618.